Skip to main content
Sds Optic Spolka Akcyjna logo

Sds Optic Spolka Akcyjna — Investor Relations & Filings

Ticker · SDS ISIN · PLSDSOP00013 LEI · 259400G9MUCF7RQLHQ45 WAR Professional, scientific and technical activities
Open in API
Filings indexed 180 across all filing types
Latest filing 2026-05-13 Capital/Financing Update
Country PL Poland
Listing WAR SDS

About Sds Optic Spolka Akcyjna

http://sdsoptic.pl

Sds Optic Spolka Akcyjna is a biotechnology company that develops diagnostic solutions for oncology and infectious diseases. Its flagship technology, inPROBE®, is a fiber-optic microsensor that combines photonics and molecular biology for the real-time, point-of-care detection of cancer biomarkers, such as HER2 expression. This platform is designed to complement existing diagnostic methods to improve access to targeted therapies. In addition to its diagnostic focus, the company provides custom antibody development and small-scale manufacturing services, including monoclonal and anti-idiotype antibodies. Sds Optic also offers advanced optical coating solutions using nanolayer technology to enhance the performance and durability of lenses for the optics, electronics, and medical device industries.

Recent filings

Filing Released Lang Actions
Podpisanie aneksu do umowy dofinansowania z Lubelską Agencją Wspierania Przedsiębiorczości - Content (PL)
Capital/Financing Update Classification · 80% confidence The document is a current corporate announcement (in Polish) that SDS Optic S.A. signed an amendment to a grant/financing agreement with a government agency, updating the project completion date. It contains no financial statements or voting results—rather it informs investors of a financing arrangement change. This corresponds to “Capital/Financing Update” (CAP).
2026-05-13 Polish
Osiągnięcie kamienia milowego w postaci przyjęcia strategii regulacyjnej na rynek UE dla nowego wyrobu medycznego - Content (PL)
Regulatory Filings Classification · 80% confidence The document is a current report (Polish ESPI) announcing that the company’s management board has adopted and accepted EU regulatory strategies for its medical devices. It is a corporate regulatory update about progress milestones in product approval and does not contain financial statements, voting results, capital changes, or annual/interim report content. It falls into the general category for miscellaneous regulatory announcements. Therefore, it should be classified as a Regulatory Filing (RNS).
2026-05-12 Polish
Realizacja kamienia milowego w postaci uzyskania na kolejne 3 lata certyfikatu SZJ zgodnie z normą ISO 13485:2016 w rozszerzonym zakresie - Content (PL)
Regulatory Filings Classification · 85% confidence The document is a brief current report from SDS Optic S.A. informing about the receipt of an ISO 13485:2016 quality management certification. It is not a financial report, earnings release, or management presentation, but rather a regulatory compliance announcement. It fits under the generic Regulatory Filings category (RNS).
2026-04-29 Polish
zal01_Powiadomienie_nr_1.pdf
Director's Dealing Classification · 92% confidence The document is a notification under Article 19(1) of MAR detailing a transaction in the issuer’s shares by a person closely associated with a board member (including instrument description, volume, price, date, and insider details). This matches an insider/director’s dealing report.
2026-04-21 Polish
Informacja o transakcji dokonanej przez osobę blisko związaną z osobą pełniącą obowiązki zarządcze - Content (PL)
Director's Dealing Classification · 80% confidence The document is a short current report informing that the company has received notification of a transaction by a person closely related to an executive. This matches the definition of insider share transactions by company directors/executives. Therefore, it is classified as Director’s Dealing (DIRS).
2026-04-21 Polish
zal02_Zawiadomienie_nr_2.pdf
Regulatory Filings Classification · 82% confidence The document is a Polish regulatory notification filed under the Public Offer Act (art. 69 in conjunction with art. 87) by participants in a shareholders’ agreement (“porozumienie akcjonariuszy”). It details pre- and post-issuance shareholdings, voting rights and registration of a capital increase. It is not an earnings release, financial report, governance code, or dividend notice, nor does it announce an AGM or M&A transaction. This is a mandatory regulatory disclosure that does not fit any other specific category, making it a general Regulatory Filing (fallback).
2026-03-26 Polish

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.